Antoine is a Senior Partner at Truffle Capital. Prior to joining Truffle Capital, Antoine had experiences at Novartis Pharma (oncology business unit) and Forvis Mazars (Audit and Transaction Services). His expertise and track record cover the creation, structuration and financing of healthcare companies from early R&D to commercial stage, IPO or trade sale. Antoine is co-founder and board member of BariaTek Medical (clinical-stage endoscopic implant to treat obesity) as well as Skinosive (bioadhesive UV filters for long-lasting sun protection). He was previously the CEO of SpikImm, founded by Truffle Capital and the Institut Pasteur to develop monoclonal antibodies to prevent viral diseases in immunocompromised patients. Pharmacist and graduated from the ESSEC Business School (Master in Management), Antoine is a guest lecturer at Sorbonne University, Paris Cité University, ESSEC Business School, as well as a regular jury member at X-HEC Entrepreneurs.